Kent L. Erickson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kent L. Erickson has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Neil E. Hubbard
University of California
6 shared publicationsJung-Hyun Kim
3 shared publicationsEdward A. Medina
2 shared publications- Neil E. Hubbard
Department of Cell Biology and Human Anatomy, University of California, School of Medicine, Davis 95616-8643, USA
2 shared publications Vincent Ziboh
Department of Dermatology, University of California, School of Medicine, Davis, CA 95616-8643, USA
2 shared publicationsDarshan S. Kelley
U.S. Department of Agriculture/Western Human Nutrition Research Center University of California One Shields Ave Davis California 95616
1 shared publication
Latest Publications
- 12 May 2010
- Published by Springer Nature
- p. 121-131
Alteration of Human Body Composition and Tumorigenesis by Isomers of Conjugated Linoleic Acid
- 12 May 2010
- Published by Springer Nature
- p. 121-131
Alteration of Human Body Composition and Tumorigenesis by Isomers of Conjugated Linoleic Acid
- 5 April 2010
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 82 (4-6) , 237-241
Fatty acids and breast cancer: The role of stem cells
- 5 April 2010
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 82 (4-6) , 237-241
Fatty acids and breast cancer: The role of stem cells
- 1 November 2009
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 67 (suppl_2) , S172-S182
Assessing mucosal immunity with new concepts and innovative, time-honored strategies
A healthy mucosal immune system prevents numerous diseases whether they are caused by pathogens or faulty tolerance to non-pathogenic antigens. Some
- 1 November 2009
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 67 (suppl_2) , S172-S182
Assessing mucosal immunity with new concepts and innovative, time-honored strategies
A healthy mucosal immune system prevents numerous diseases whether they are caused by pathogens or faulty tolerance to non-pathogenic antigens. Some
- 1 October 2005
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1736 (3) , 244-250
Attenuation of breast tumor cell growth by conjugated linoleic acid via inhibition of 5-lipoxygenase activating protein
- 1 October 2005
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1736 (3) , 244-250
Attenuation of breast tumor cell growth by conjugated linoleic acid via inhibition of 5-lipoxygenase activating protein
- 21 February 2005
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1687 (1-3) , 103-109
Conjugated linoleic acid reduction of murine mammary tumor cell growth through 5-hydroxyeicosatetraenoic acid
- 21 February 2005
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1687 (1-3) , 103-109
Conjugated linoleic acid reduction of murine mammary tumor cell growth through 5-hydroxyeicosatetraenoic acid
- Open Access
- 1 January 2002
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 75 (1) , 5-7
Dietary pattern analysis: a different approach to analyzing an old problem, cancer of the esophagus and stomach
The roles that some foods and dietary components may play in the etiology and pathogenesis of cancer of the esophagus and stomach have been recognized for several years. Most of the evidence for those roles has come from ecologic, descriptive studies, as well as from case-control and cohort-type studies. Although both tumor sites are part of the digestive system, the pathogenesis of the tumors and their relation to specific dietary components may differ.
- 1 January 2002
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 75 (1) , 5-7
Open AccessDietary pattern analysis: a different approach to analyzing an old problem, cancer of the esophagus and stomach
The roles that some foods and dietary components may play in the etiology and pathogenesis of cancer of the esophagus and stomach have been recognized for several years. Most of the evidence for those roles has come from ecologic, descriptive studies, as well as from case-control and cohort-type studies. Although both tumor sites are part of the digestive system, the pathogenesis of the tumors and their relation to specific dietary components may differ.
- 1 September 2001
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 65 (3) , 123-131
Prostaglandin E2 modulation of vascular endothelial growth factor production in murine macrophages
- 1 September 2001
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 65 (3) , 123-131
Prostaglandin E2 modulation of vascular endothelial growth factor production in murine macrophages
- 1 September 2000
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 182 (s1) , S5-S10
Micronutrients and Innate Immunity
Micronutrients such as zinc, selenium, iron, copper, β-carotene, vitamins A, C, and E, and folic acid can influence several components of innate immunity. Select micronutrients play an important role in alteration of oxidant-mediated tissue injury, and phagocytic cells produce reactive oxidants as part of the defense against infectious agents. Thus, adequate micronutrients are required to prevent damage of cells participating in innate immunity. Deficiencies in zinc and vitamins A and D may reduce natural killer cell function, whereas supplemental zinc or vitamin C may enhance their activity. The specific effects of micronutrients on neutrophil functions are not clear. Select micronutrients may play a role in innate immunity associated with some disease processes. Future studies should focus on issues such as age-related micronutrient status and innate immunity, alterations of micronutrients in disease states and their effect on innate immunity, and the mechanisms by which micronutrients alter innate immunity.
- 1 September 2000
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 182 (s1) , S5-S10
Micronutrients and Innate Immunity
Micronutrients such as zinc, selenium, iron, copper, β-carotene, vitamins A, C, and E, and folic acid can influence several components of innate immunity. Select micronutrients play an important role in alteration of oxidant-mediated tissue injury, and phagocytic cells produce reactive oxidants as part of the defense against infectious agents. Thus, adequate micronutrients are required to prevent damage of cells participating in innate immunity. Deficiencies in zinc and vitamins A and D may reduce natural killer cell function, whereas supplemental zinc or vitamin C may enhance their activity. The specific effects of micronutrients on neutrophil functions are not clear. Select micronutrients may play a role in innate immunity associated with some disease processes. Future studies should focus on issues such as age-related micronutrient status and innate immunity, alterations of micronutrients in disease states and their effect on innate immunity, and the mechanisms by which micronutrients alter innate immunity.
Conjugated linoleic acid supplementation in humans: Effects on circulating leptin concentrations and appetite
Conjugated linoleic acid (CLA) has been demonstrated to reduce body fat in animals. However, the mechanism by which this reduction occurs is unknown. Leptin may mediate the effect of CLA to decrease body fat. We assessed the effects of 64 d of CLA supplementation (3 g/d) on circulating leptin, insulin, glucose, and lactate concentrations in healthy women. Appetite was assessed as a physiological correlate of changes in circulating leptin levels. Analysis of plasma leptin concentrations adjusted for adiposity by using fat mass as a covariate showed that CLA supplementation significantly decreased circulating leptin concentrations in the absence of any changes of fat mass. Mean leptin levels decreased over the first 7 wk and then returned to baseline levels over the last 2 wk of the study in the CLA‐treated group. Appetite parameters measured at around the time when the greatest decreases in leptin levels were observed showed no significant differences between supplementation and baseline determinations in the CLA‐supplemented group or between the CLA and placebo‐supplemented groups. There was a nonsignificant trend for mean insulin levels to increase toward the end of the supplementation period in CLA‐treated subjects. CLA did not affect plasma glucose and lactate over the treatment period. Thus, 64 d of CLA supplementation in women produced a transient decrease in leptin levels but did not alter appetite. CLA did not affect these parameters in a manner that promoted decreases of adiposity.
Conjugated linoleic acid supplementation in humans: Effects on circulating leptin concentrations and appetite
Conjugated linoleic acid (CLA) has been demonstrated to reduce body fat in animals. However, the mechanism by which this reduction occurs is unknown. Leptin may mediate the effect of CLA to decrease body fat. We assessed the effects of 64 d of CLA supplementation (3 g/d) on circulating leptin, insulin, glucose, and lactate concentrations in healthy women. Appetite was assessed as a physiological correlate of changes in circulating leptin levels. Analysis of plasma leptin concentrations adjusted for adiposity by using fat mass as a covariate showed that CLA supplementation significantly decreased circulating leptin concentrations in the absence of any changes of fat mass. Mean leptin levels decreased over the first 7 wk and then returned to baseline levels over the last 2 wk of the study in the CLA‐treated group. Appetite parameters measured at around the time when the greatest decreases in leptin levels were observed showed no significant differences between supplementation and baseline determinations in the CLA‐supplemented group or between the CLA and placebo‐supplemented groups. There was a nonsignificant trend for mean insulin levels to increase toward the end of the supplementation period in CLA‐treated subjects. CLA did not affect plasma glucose and lactate over the treatment period. Thus, 64 d of CLA supplementation in women produced a transient decrease in leptin levels but did not alter appetite. CLA did not affect these parameters in a manner that promoted decreases of adiposity.